Cargando…

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge

Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited, but its prevalence among elite athletes and nonpr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gild, Matti L, Stuart, Mark, Clifton-Bligh, Roderick J, Kinahan, Audrey, Handelsman, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387720/
https://www.ncbi.nlm.nih.gov/pubmed/35438767
http://dx.doi.org/10.1210/clinem/dgac223
_version_ 1784770070051815424
author Gild, Matti L
Stuart, Mark
Clifton-Bligh, Roderick J
Kinahan, Audrey
Handelsman, David J
author_facet Gild, Matti L
Stuart, Mark
Clifton-Bligh, Roderick J
Kinahan, Audrey
Handelsman, David J
author_sort Gild, Matti L
collection PubMed
description Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited, but its prevalence among elite athletes and nonprohibited status remains controversial. A corollary of prohibiting hormones for elite sports is that endocrinologists must be aware of a professional athlete’s risk of disqualification for using prohibited hormones and/or to certify Therapeutic Use Exemptions, which allow individual athletes to use prohibited substances for valid medical indications. This narrative review considers the status of TH within the framework of the WADA Code criteria for prohibiting substances, which requires meeting 2 of 3 equally important criteria of potential performance enhancement, harmfulness to health, and violation of the spirit of sport. In considering the valid clinical uses of TH, the prevalence of TH use among young adults, the reason why some athletes seek to use TH, and the pathophysiology of sought-after and adverse effects of TH abuse, together with the challenges of detecting TH abuse, it can be concluded that, on the basis of present data, prohibition of TH in elite sport is neither justified nor feasible.
format Online
Article
Text
id pubmed-9387720
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93877202022-08-19 Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge Gild, Matti L Stuart, Mark Clifton-Bligh, Roderick J Kinahan, Audrey Handelsman, David J J Clin Endocrinol Metab Online Only Articles Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited, but its prevalence among elite athletes and nonprohibited status remains controversial. A corollary of prohibiting hormones for elite sports is that endocrinologists must be aware of a professional athlete’s risk of disqualification for using prohibited hormones and/or to certify Therapeutic Use Exemptions, which allow individual athletes to use prohibited substances for valid medical indications. This narrative review considers the status of TH within the framework of the WADA Code criteria for prohibiting substances, which requires meeting 2 of 3 equally important criteria of potential performance enhancement, harmfulness to health, and violation of the spirit of sport. In considering the valid clinical uses of TH, the prevalence of TH use among young adults, the reason why some athletes seek to use TH, and the pathophysiology of sought-after and adverse effects of TH abuse, together with the challenges of detecting TH abuse, it can be concluded that, on the basis of present data, prohibition of TH in elite sport is neither justified nor feasible. Oxford University Press 2022-04-19 /pmc/articles/PMC9387720/ /pubmed/35438767 http://dx.doi.org/10.1210/clinem/dgac223 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Online Only Articles
Gild, Matti L
Stuart, Mark
Clifton-Bligh, Roderick J
Kinahan, Audrey
Handelsman, David J
Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
title Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
title_full Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
title_fullStr Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
title_full_unstemmed Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
title_short Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
title_sort thyroid hormone abuse in elite sports: the regulatory challenge
topic Online Only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387720/
https://www.ncbi.nlm.nih.gov/pubmed/35438767
http://dx.doi.org/10.1210/clinem/dgac223
work_keys_str_mv AT gildmattil thyroidhormoneabuseinelitesportstheregulatorychallenge
AT stuartmark thyroidhormoneabuseinelitesportstheregulatorychallenge
AT cliftonblighroderickj thyroidhormoneabuseinelitesportstheregulatorychallenge
AT kinahanaudrey thyroidhormoneabuseinelitesportstheregulatorychallenge
AT handelsmandavidj thyroidhormoneabuseinelitesportstheregulatorychallenge